key: cord-0749346-egr3qzc5
authors: Cabral, Gonçalo; Gonçalves, Carolina; Serrazina, Filipa; Sá, Francisca
title: MRI Negative Myelitis Induced by Pfizer-BioNTech COVID-19 Vaccine
date: 2021-12-30
journal: J Clin Neurol
DOI: 10.3988/jcn.2022.18.1.120
sha: 44b3fa01a9a9e39c8c2118c9b186aa93e87acc78
doc_id: 749346
cord_uid: egr3qzc5

nan

do not have relevant MRI findings. 6 Several cases of TM have been reported after the administration of the different vaccines, including those for HBV, HPV, seasonal influenza, measles-mumps-rubella (MMR), polio, and diphtheria, with symptoms occurring from a few days to 3 months following inoculation. 4, 7 More recently, during the trial phase an association was found between the recombinant Oxford-AstraZeneca COVID-19 vaccine, and two instances of TM, but in one of those cases the association was the association was likely to have been coincidental. 2, 8 After the beginning of mass vaccination, there was another case report of TM associated with the Oxford-AstraZeneca COVID-19 vaccine, with symptom onset occurring at 8 days after vaccine administration, which was responsive to intravenous methylprednisolone. 9 Three mechanisms via which vaccines can induce TM have been proposed 1) molecular mimicry; 2) epitope spreading, or 3) polyclonal activation of B lymphocytes. 4 Neurological side effects in clinical trials of the Pfizer-BioNTech COVID-19 vaccine were rare, and only included Bell's palsy. 1, 8 After the vaccine started to be rolled out around the world, one case of Guillain-Barré syndrome after the first dose of the Pfizer-Bi-oNTech COVID-19 vaccine was reported. 10 The technology underlying the Pfizer-BioNTech COVID-19 vaccine relies on messenger RNA (mRNA), and since the mRNA technique is new in vaccine manufacturing, potential adverse effects are not yet known, especially neurological ones. 1 We hypothesize that the immune response to this vaccine triggered a transitory autoimmune process in our patient.

To our knowledge, this is the first reported case of TM after receiving the Pfizer-BioNTech. This case highlights that is essential to follow possible vaccine side effects in the real world, including neurological ones. However, it should be remembered that the risk of neurological complications or other adverse effects associated with COVID-19 vaccination is very low and that the benefits of vaccination outweigh any potential risks or side effects.

Informed consent was obtained from the patient.

Data sharing not applicable to this article as no datasets were generated or analyzed during the study. 

Gonçalo

Minor to moderate side effects of Pfizer-BioNTech CO-VID-19 vaccine among Saudi residents: a retrospective cross-sectional study

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

Transverse myelitis and vaccines: a multi-analysis

An approach to the diagnosis of acute transverse myelitis

Diagnosis and differential diagnosis of acute transverse myelopathy. The role of neuroradiological investigations and review of the literature

Do vaccines have a role as a cause of autoimmune neurological syndromes?

ANA investigates: neurological complications of COVID-19 vaccines

Agarwal V. COVID-19 vaccination-associated myelitis

Neurological complications of COVID-19: Guillain-Barre syndrome following Pfizer COVID-19 vaccine

The authors have no potential conflicts of interest to disclose.

None